Logo image of ORIC

ORIC PHARMACEUTICALS INC (ORIC) Stock Analyst Ratings

NASDAQ:ORIC - Nasdaq - US68622P1093 - Common Stock - Currency: USD

9.85  -1.38 (-12.29%)

After market: 9.9 +0.05 (+0.51%)

Buy % Consensus

89

ChartMill assigns a Buy % Consensus number of 89% to ORIC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 19.1. This target is 93.93% above the current price.
ORIC was analyzed by 18 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about ORIC.
In the previous month the buy percentage consensus was at a similar level.
ORIC was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
ORIC Historical Analyst RatingsORIC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -56 -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 9.8513.1319.3819.1026.25 - 33.30% 96.75% 93.93% 166.50%
ORIC Current Analyst RatingORIC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-02-11 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-10 Guggenheim Maintains Buy -> Buy
2025-02-06 JP Morgan Maintains Overweight -> Overweight
2025-01-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-01-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-31 Jones Trading Initiate Buy
2024-10-31 Wells Fargo Initiate Overweight
2024-09-23 Cantor Fitzgerald Reiterate Overweight
2024-09-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-10 Wedbush Reiterate Outperform -> Outperform
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-09-06 Stifel Initiate Buy
2024-08-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-13 Oppenheimer Maintains Outperform -> Outperform
2024-08-13 Wedbush Reiterate Outperform -> Outperform
2024-07-17 Wedbush Reiterate Outperform -> Outperform
2024-07-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-10 Oppenheimer Maintains Outperform -> Outperform
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-05-28 Cantor Fitzgerald Reiterate Overweight
2024-05-07 Citigroup Maintains Buy -> Buy
2024-03-27 JP Morgan Maintains Overweight -> Overweight
2024-03-21 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-12 Oppenheimer Maintains Outperform -> Outperform
2024-03-12 Wedbush Reiterate Outperform -> Outperform
2024-03-12 Baird Reiterate Outperform -> Outperform
2024-03-01 Wedbush Maintains Outperform -> Outperform
2024-02-23 Cantor Fitzgerald Initiate Overweight
2023-12-13 HC Wainwright & Co. Maintains Buy -> Buy